150 related articles for article (PubMed ID: 32269688)
1. Low expression of RECK in oral squamous cell carcinoma patients induces a shorter survival rate through an imbalance of RECK/MMPs.
Yuan J; Li W; Zhu J; Deng S; Tao X
Int J Clin Exp Pathol; 2020; 13(3):501-508. PubMed ID: 32269688
[TBL] [Abstract][Full Text] [Related]
2. MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK.
Bao WW; Shi YL; Ma Y; Qu XH; Pang GM; Yang L
Histol Histopathol; 2021 Mar; 36(3):355-365. PubMed ID: 33447989
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas.
Long NK; Kato K; Yamashita T; Makita H; Toida M; Hatakeyama D; Hara A; Mori H; Shibata T
Oral Oncol; 2008 Nov; 44(11):1052-8. PubMed ID: 18485791
[TBL] [Abstract][Full Text] [Related]
4. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T
Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
[TBL] [Abstract][Full Text] [Related]
5. Expression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis.
Zhou X; Huang S; Jiang L; Zhang S; Li W; Chen Z; Zhang D
Oncol Lett; 2014 May; 7(5):1549-1555. PubMed ID: 24765174
[TBL] [Abstract][Full Text] [Related]
6. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
[TBL] [Abstract][Full Text] [Related]
7. Expression of RECK and MMPs in Hepatoblastoma and Neuroblastoma and Comparative Analysis on the Tumor Metastasis.
Xu M; Wang HF; Zhang HZ
Asian Pac J Cancer Prev; 2015; 16(9):4007-11. PubMed ID: 25987077
[TBL] [Abstract][Full Text] [Related]
8. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
Tang Y; Xiao Y; Liao R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
[TBL] [Abstract][Full Text] [Related]
9. MMP-9/RECK Imbalance: A Mechanism Associated with High-Grade Cervical Lesions and Genital Infection by Human Papillomavirus and Chlamydia trachomatis.
Discacciati MG; Gimenes F; Pennacchi PC; Faião-Flores F; Zeferino LC; Derchain SM; Teixeira JC; Costa MC; Zonta M; Termini L; Boccardo E; Longatto-Filho A; Consolaro ME; Villa LL; Maria-Engler SS
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1539-47. PubMed ID: 26261088
[TBL] [Abstract][Full Text] [Related]
10. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
Cho YB; Lee WY; Song SY; Shin HJ; Yun SH; Chun HK
Hum Pathol; 2007 Nov; 38(11):1603-10. PubMed ID: 17669467
[TBL] [Abstract][Full Text] [Related]
12. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
13. Plasma Matrix Metalloproteinase-1 as a Prognostic Biomarker in Oral Cavity Squamous Cell Carcinoma.
Tsai TY; Kao HK; Huang Y; Chang YT; Young CK; Hung SY; Chang YS; Yu JS; Chang KP
Cancer Manag Res; 2022; 14():3459-3468. PubMed ID: 36545225
[TBL] [Abstract][Full Text] [Related]
14. RECK is not an independent prognostic marker for breast cancer.
Gomes LR; Fujita A; Mott JD; Soares FA; Labriola L; Sogayar MC
BMC Cancer; 2015 Oct; 15():660. PubMed ID: 26449734
[TBL] [Abstract][Full Text] [Related]
15. Low expression of RECK indicates a shorter survival for patients with invasive breast cancer.
Zhang Y; Cheng S; Zhang G; Ma W; Liu Y; Zhao R; Zhang Q; Pang D
Cancer Sci; 2012 Jun; 103(6):1084-9. PubMed ID: 22404079
[TBL] [Abstract][Full Text] [Related]
16. [Expression levels of MMP-14, ING4 and HIF-1α in 60 patients with oral squamous cell carcinoma and their clinical significance].
Fu ZY; Tao F
Shanghai Kou Qiang Yi Xue; 2020 Dec; 29(6):642-646. PubMed ID: 33778834
[TBL] [Abstract][Full Text] [Related]
17. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis.
Mao Y; Zhang W; Zhang R; Zuo J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3153-3162. PubMed ID: 31349748
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.
Gomes LR; Terra LF; Wailemann RA; Labriola L; Sogayar MC
BMC Cancer; 2012 Jan; 12():26. PubMed ID: 22260435
[TBL] [Abstract][Full Text] [Related]
19. High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis.
Pu Y; Wang L; Wu H; Feng Z; Wang Y; Guo C
Oncol Rep; 2014 Jun; 31(6):2644-50. PubMed ID: 24700287
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of plasma miR-1290 expression in patients with oral squamous cell carcinoma].
Chen XM; Liu ZZ; Lin JN
Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Aug; 38(4):371-375. PubMed ID: 32865353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
